FDA Inspection 1218205 — Beth Israel Deaconess Medical Center
The FDA completed an inspection of Beth Israel Deaconess Medical Center on Sep 11, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Boston, MA (United States)